Literature DB >> 29615304

Corneal Changes in Trastuzumab Emtansine Treatment.

Elke O Kreps1, Thierry Derveaux2, Hannelore Denys3.   

Abstract

Entities:  

Keywords:  Antibody–drug conjugates; Autologous serum; Corneal toxicity; HER2; Microcystic epitheliopathy

Mesh：

Substances：

Year:  2018        PMID： 29615304     DOI： 10.1016/j.clbc.2018.03.005

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN： 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  6 in total

Review 1.  Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review.

Authors:  Shruthi Harish Bindiganavile; Nita Bhat; Andrew G Lee; Dan S Gombos; Nagham Al-Zubidi
Journal:  J Immunother Precis Oncol       Date:  2021-02-25

2.  Refractive Shifts and Changes in Corneal Curvature Associated With Antibody-Drug Conjugates.

Authors:  Julia Canestraro; Malin Hultcrantz; Shanu Modi; Paul A Hamlin; Alexander N Shoushtari; Jason A Konner; William P Tew; Neil M Iyengar; Murk Heinemann; David H Abramson; Jasmine H Francis
Journal:  Cornea       Date:  2021-11-23       Impact factor: 3.152

Review 3.  Ocular Toxicity of Targeted Anticancer Agents.

Authors:  Blake H Fortes; Prashant D Tailor; Lauren A Dalvin
Journal:  Drugs       Date:  2021-03-31       Impact factor: 9.546

4.  Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.

Authors:  Asim V Farooq; Simona Degli Esposti; Rakesh Popat; Praneetha Thulasi; Sagar Lonial; Ajay K Nooka; Andrzej Jakubowiak; Douglas Sborov; Brian E Zaugg; Ashraf Z Badros; Bennie H Jeng; Natalie S Callander; Joanna Opalinska; January Baron; Trisha Piontek; Julie Byrne; Ira Gupta; Kathryn Colby
Journal:  Ophthalmol Ther       Date:  2020-07-25

5.  A randomized, double-blind, parallel control study to evaluate the biosimilarity of QL1209 with Perjeta® in healthy male subjects.

Authors:  Yuanyuan Sun; Heng Yang; Xiaoyan Yang; Shuang Yang; Can Guo; Honghui Chen; Chang Cui; Yuxia Xiang; Guoping Yang; Jie Huang
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

6.  Burst of Corneal Dendritic Cells during Trastuzumab and Paclitaxel Treatment.

Authors:  Katharina A Sterenczak; Nadine Stache; Sebastian Bohn; Stephan Allgeier; Bernd Köhler; Andreas Bartschat; Christian George; Rudolf F Guthoff; Oliver Stachs; Angrit Stachs
Journal:  Diagnostics (Basel)       Date:  2021-05-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.